BioXcel Therapeutics Announces Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501

NEXT STORY
Banner Health Innovates with LifeLink Chatbots to Enable Virtual Waiting Rooms for Telehealth and In-Person Appointments
PREV STORY
TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready to Dilute Cyclophosphamide

author_avatar
NASDAQ Market News

RENNOVA HEALTH REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

WEST PALM BEACH, Fla, June 19, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: ...

author_avatar
NASDAQ Market News

Signature Resources Announces Appointment of Rickardo Welyhorsky as COO & Provides Lingman Lake Project Update

author_avatar
NASDAQ Market News